As a result, we observed that the outcomes of FLT3-ITD-mutated subgroups—FLT3-ITDhigh and NPM1mut (n = 13), FLT3-ITDlow, and NPM1wt (n = 9), and FLT3-ITDhigh and NPM1wt AML (n = 8)—did not significantly differ after transplantation. Here, FLT3 is linked to acute myeloid leukemia.